
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Prepared to a prescriber's order for one patient. Not FDA-approved.
This is a compounded slow release capsule containing brompheniramine maleate, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.
These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.
FDA-approved products listed in the directory contain brompheniramine only in combination with dextromethorphan and pseudoephedrine, in syrup and solution forms. No finished brompheniramine product of any kind is listed in capsule form.
This is a solid, nonaqueous dose form. Under USP <795>, nonaqueous preparations carry longer default beyond-use dates than water-containing ones. The date printed on the label is the one to follow.
Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.
Brompheniramine maleate is a sedating antihistamine for allergy and cold symptoms, taken by mouth, that a pharmacy may compound when a prescriber orders it.
Brompheniramine is a first-generation antihistamine of the alkylamine class, closely related to chlorpheniramine. It competes with histamine at H1 receptors, which lessens sneezing, runny nose and itching, and it also has drying (anticholinergic) and sedating effects. Most manufactured products are combinations. Prescription brompheniramine, pseudoephedrine and dextromethorphan syrups and a brompheniramine and pseudoephedrine syrup are FDA-approved generics (ANDA) labeled for relief of coughs and upper respiratory symptoms, including nasal congestion, with allergy or the common cold. Many nonprescription products, such as Children's Dimetapp Cold and Allergy, are marketed under the OTC monograph rather than an approved application, and at least one nonprescription liquid (Rynex PSE) is filed as unapproved drug other. A prescriber might order brompheniramine compounded alone, in a strength or form that is not manufactured, or without a dye or other excipient. Compounded preparations are not FDA-approved and require a prescription.
Brompheniramine products carry no boxed warning. Prescription combination labels say not to use them in newborns or premature infants, in nursing mothers, or with severe high blood pressure or severe heart disease, and not to use antihistamines to treat asthma or other lower airway conditions. In overdose, especially in infants and small children, antihistamines can cause hallucinations, seizures and death; MedlinePlus says not to give these products to children under 6. Drowsiness is common, and young children may become excitable; avoid driving until you know how it affects you, and avoid alcohol, sedatives and tranquilizers, which add to drowsiness. Ask first if you have glaucoma, trouble urinating from an enlarged prostate, or a breathing problem such as asthma. MAO inhibitors can prolong and intensify its drying effects. MedlinePlus says adults 65 and older should not usually take it. The prescription label advises use in pregnancy only if clearly needed. Lactation sources differ: LactMed says small, occasional doses are not expected to harm a breastfed infant, while the prescription combination label says not to use it while nursing. Talk to your prescriber or pharmacist about side effects.
Brompheniramine is an alkylamine H1-receptor antagonist with anticholinergic and sedative properties (label); LiverTox notes it is also available as the dextrorotatory isomer, dexbrompheniramine. Per the prescription combination label, it is well absorbed orally, peak plasma levels after a single dose occur at about 5 hours, the liver is assumed to be the main site of metabolism, and urinary excretion of metabolites is the main route of elimination. Labeled indication: relief of coughs and upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold (brompheniramine, pseudoephedrine and dextromethorphan oral syrup, ANDA). OTC monograph labels list temporary relief of runny nose, sneezing, itching of the nose or throat, and itchy, watery eyes due to hay fever. Use caution with bronchial asthma, narrow-angle glaucoma, gastrointestinal obstruction and bladder neck obstruction. Antihistamines are more likely to cause dizziness, sedation and hypotension in older patients. The most frequent adverse reactions are sedation, dry mouth, thickened bronchial secretions and dizziness; others listed include difficult urination, hemolytic anemia, thrombocytopenia and agranulocytosis. LiverTox rates it an unlikely cause of clinically apparent liver injury (likelihood score E). LactMed notes that larger doses or prolonged use may reduce milk supply. Not a controlled substance on these labels. Dosing is per prescriber.
Swallow the capsule whole with fluid. Do not crush, chew, divide or open it, and do not dissolve it in liquid, because that can release the full dose at once. Take it at the same times each day as your label directs. Slow release forms are not meant for feeding tubes; ask your pharmacist if you need a different form.
These are nonaqueous capsules, so a USP <795> default beyond-use date of up to 180 days usually applies. Store in a closed container at room temperature, away from heat, moisture and direct light, and out of reach of children. Discard after the beyond-use date on the label.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth